BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11068102)

  • 1. Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor.
    Moreno D; Gourlet P; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
    Peptides; 2000 Oct; 21(10):1543-9. PubMed ID: 11068102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
    Juarranz MG; De Neef P; Robberecht P
    Prostate; 1999 Sep; 41(1):1-6. PubMed ID: 10440869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.
    Juarranz MG; Van Rampelbergh J; Gourlet P; De Neef P; Cnudde J; Robberecht P; Waelbroeck M
    Mol Pharmacol; 1999 Dec; 56(6):1280-7. PubMed ID: 10570056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of a selective antagonist and agonist of the rat VPAC(1) receptor using a combinatorial approach with vasoactive intestinal peptide 6-23 as template.
    Tams JW; Jorgensen RM; Holm A; Fahrenkrug J
    Mol Pharmacol; 2000 Nov; 58(5):1035-41. PubMed ID: 11040051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide.
    Nicole P; Lins L; Rouyer-Fessard C; Drouot C; Fulcrand P; Thomas A; Couvineau A; Martinez J; Brasseur R; Laburthe M
    J Biol Chem; 2000 Aug; 275(31):24003-12. PubMed ID: 10801840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.
    Vertongen P; Solano RM; Perret J; Langer I; Robberecht P; Waelbroeck M
    Br J Pharmacol; 2001 Aug; 133(8):1249-54. PubMed ID: 11498510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
    Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
    Vertongen P; Langlet C; Langer I; Gaspard N; Robberecht P
    Peptides; 2004 Nov; 25(11):1943-9. PubMed ID: 15501526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
    Van Rampelbergh J; Juarranz MG; Perret J; Bondue A; Solano RM; Delporte C; De Neef P; Robberecht P; Waelbroeck M
    Br J Pharmacol; 2000 Jun; 130(4):819-26. PubMed ID: 10864888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass.
    Gourlet P; Vertongen P; Vandermeers A; Vandermeers-Piret MC; Rathe J; De Neef P; Waelbroeck M; Robberecht P
    Peptides; 1997; 18(3):403-8. PubMed ID: 9145428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localisation of VIP-binding sites exhibiting properties of VPAC receptors in chromaffin cells of rainbow trout (Oncorhynchus mykiss).
    Montpetit CJ; Shahsavarani A; Perry SF
    J Exp Biol; 2003 Jun; 206(Pt 11):1917-27. PubMed ID: 12728013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro properties of a high affinity selective antagonist of the VIP1 receptor.
    Gourlet P; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
    Peptides; 1997; 18(10):1555-60. PubMed ID: 9437716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction.
    Solano RM; Langer I; Perret J; Vertongen P; Juarranz MG; Robberecht P; Waelbroeck M
    J Biol Chem; 2001 Jan; 276(2):1084-8. PubMed ID: 11013258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a VIP-specific receptor in guinea pig tenia coli.
    Teng BQ; Grider JR; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of the VPAC2 receptor in peripheral tissues of the mouse.
    Harmar AJ; Sheward WJ; Morrison CF; Waser B; Gugger M; Reubi JC
    Endocrinology; 2004 Mar; 145(3):1203-10. PubMed ID: 14617572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.
    Perret J; Vertongen P; Solano RM; Langer I; Cnudde J; Robberecht P; Waelbroeck M
    Br J Pharmacol; 2002 Aug; 136(7):1042-8. PubMed ID: 12145104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig.
    Igarashi H; Ito T; Hou W; Mantey SA; Pradhan TK; Ulrich CD; Hocart SJ; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2002 Apr; 301(1):37-50. PubMed ID: 11907155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
    Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
    Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.
    Nachtergael I; Vertongen P; Langer I; Perret J; Robberecht P; Waelbroeck M
    Biochem J; 2003 Mar; 370(Pt 3):1003-9. PubMed ID: 12475394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vasoactive intestinal polypeptide on neurones of the rat suprachiasmatic nuclei in vitro.
    Reed HE; Cutler DJ; Brown TM; Brown J; Coen CW; Piggins HD
    J Neuroendocrinol; 2002 Aug; 14(8):639-46. PubMed ID: 12153466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.